{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:31:25Z","timestamp":1788298285243,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873759"],"award-info":[{"award-number":["81873759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107846","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T23:30:54Z","timestamp":1624491054000},"page":"107846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Protective effect and mechanism of nicotinamide adenine dinucleotide against optic neuritis in mice with experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-9482","authenticated-orcid":false,"given":"Jiangyuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-2880","authenticated-orcid":false,"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107846_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamaneurol.2017.3065","article-title":"Valuable Insights Into Visual Neuroplasticity After Optic Neuritis","volume":"75","author":"Toosy","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2021.107846_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/138161209787185751","article-title":"The importance of NAD in multiple sclerosis","volume":"15","author":"Penberthy","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2021.107846_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fneur.2011.00050","article-title":"Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis","volume":"2","author":"Quinn","year":"2011","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2021.107846_b0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.23.6.609","article-title":"Clinical studies of multiple sclerosis in Japan. I. A current appraisal of 83 cases","volume":"23","author":"Kuroiwa","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2021.107846_b0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tem.2012.06.005","article-title":"The dynamic regulation of NAD metabolism in mitochondria","volume":"23","author":"Stein","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2021.107846_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/138161209787185832","article-title":"Roles of NAD(+) \/ NADH and NADP(+) \/ NADPH in cell death","volume":"15","author":"Xia","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2021.107846_b0035","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2741\/2194","article-title":"NAD+ and NADH in brain functions, brain diseases and brain aging","volume":"12","author":"Ying","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.intimp.2021.107846_b0040","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1038\/ncomms6101","article-title":"NAD+ protects against EAE by regulating CD4+ T-cell differentiation","volume":"5","author":"Tullius","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107846_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.intimp.2016.07.036","article-title":"Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK\/SIRT1 signaling pathway and modulating Th1\/Th17 immune responses in mice","volume":"39","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107846_b0050","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2021.107846_b0055","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","article-title":"An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization","volume":"19","author":"Weaver","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.intimp.2021.107846_b0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-018-1208-3","article-title":"Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model","volume":"15","author":"Wilmes","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.intimp.2021.107846_b0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopha.2017.10.155","article-title":"S-allyl cysteine improves clinical and neuropathological features of experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"97","author":"Zeinali","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.107846_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.1972.01000020137004","article-title":"Optic neuritis and multiple sclerosis. An epidemiologic study","volume":"87","author":"Percy","year":"1972","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.intimp.2021.107846_b0075","doi-asserted-by":"crossref","unstructured":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 65, (2008) 727\u2013732. doi:10.1001\/archneur.65.6.727.","DOI":"10.1001\/archneur.65.6.727"},{"key":"10.1016\/j.intimp.2021.107846_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2012.01.007","article-title":"NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia","volume":"512","author":"Zheng","year":"2012","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.intimp.2021.107846_b0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med."},{"key":"10.1016\/j.intimp.2021.107846_b0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.intimp.2021.107846_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/exer.1998.0537","article-title":"Putative role of calpain in the pathophysiology of experimental optic neuritis","volume":"67","author":"Shields","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2021.107846_b0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.exer.2008.05.017","article-title":"Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis","volume":"87","author":"Shindler","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2021.107846_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2016.06.008","article-title":"Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis","volume":"298","author":"Horstmann","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2021.107846_b0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-019-0768-5","article-title":"Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis","volume":"7","author":"Manogaran","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2021.107846_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-019-0767-6","article-title":"Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis","volume":"7","author":"Jin","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2021.107846_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1682\/JRRD.2004.08.0111","article-title":"Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement","volume":"43","author":"Cudrici","year":"2006","journal-title":"J Rehabil. Res. Dev."},{"key":"10.1016\/j.intimp.2021.107846_b0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ajpath.2013.04.016","article-title":"Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis","volume":"183","author":"Cui","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2021.107846_b0130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopha.2017.11.066","article-title":"Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis","volume":"96","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.107846_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jnc.12064","article-title":"Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats","volume":"124","author":"Das","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2021.107846_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2021.107846_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107092","article-title":"Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome","volume":"90","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107846_b0150","article-title":"The combined treatment of NAD(+) and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"350","author":"Sun","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2021.107846_b0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12017-015-8368-4","article-title":"Roles of Treg\/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimental Autoimmune Optic Neuritis Chronologically","volume":"17","author":"Liu","year":"2015","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.intimp.2021.107846_b0160","first-page":"332","article-title":"Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL\/6 mice","volume":"22","author":"Larabee","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.intimp.2021.107846_b0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107846_b0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tips.2004.12.009","article-title":"The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension","volume":"26","author":"Porcu","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2021.107846_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.intimp.2021.107846_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-5960-2-3","article-title":"SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease","volume":"2","author":"Khan","year":"2014","journal-title":"Acta Neuropathol. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921004823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:25:09Z","timestamp":1747308309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921004823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"alternative-id":["S1567576921004823"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107846","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect and mechanism of nicotinamide adenine dinucleotide against optic neuritis in mice with experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107846"}}